Positive screening for depression on PHQ-9 (Patient Health Questionnaire 9)
Related entities
Findings (27)
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22
None
improvementAmong PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after
Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22